Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Genetic landscape of congenital insensitivity to pain and hereditary sensory and autonomic neuropathies.

Lischka A. et al, (2023), Brain

Estimating motor unit numbers from a CMAP scan: Repeatability study on three muscles at 15 centres.

Sørensen DM. et al, (2023), Clin Neurophysiol, 151, 92 - 99

Utilising clinical parameters to improve the selection of nerve biopsy candidates.

Kopanidis P. et al, (2023), Intern Med J

Epidemiology of neuropathic pain: An analysis of prevalence and associated factors in UK Biobank

Baskozos G. et al, (2023), Pain Reports, 8

Investigating genotype-phenotype relationship of extreme neuropathic pain disorders in a national cohort: ’NIHR Bioresources Rare Disease – Neuropathic Pain Disorders’

THEMISTOCLEOUS A. et al, (2022), Brain Communications

Classification of painful or painless diabetic peripheral neuropathy and identification of the most powerful predictors using machine learning models in large cross-sectional cohorts.

Baskozos G. et al, (2022), BMC Med Inform Decis Mak, 22

Malleability of the cortical hand map following a finger nerve block.

Wesselink DB. et al, (2022), Sci Adv, 8

Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study.

Themistocleous AC. et al, (2022), Ann Neurol, 91, 506 - 520

Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry

Pizzamiglio C. et al, (2022), European Journal of Neurology

Nav1.7 is required for normal C-low threshold mechanoreceptor function in humans and mice.

Middleton SJ. et al, (2021), Brain

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993

Assessing inter-rater reproducibility in MScanFit MUNE in a 6-subject, 12-rater "Round Robin" setup.

Sørensen DM. et al, (2021), Neurophysiol Clin

Leucine-Rich Glioma-Inactivated 1 versus Contactin-Associated Protein-like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons.

Ramanathan S. et al, (2021), Ann Neurol, 90, 683 - 690

Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management.

Jensen TS. et al, (2021), Brain, 144, 1632 - 1645

Studying human nociceptors: from fundamentals to clinic.

Middleton SJ. et al, (2021), Brain, 144, 1312 - 1335

Novel and Emerging Electrophysiological Biomarkers of Diabetic Neuropathy and Painful Diabetic Neuropathy.

Marshall A. et al, (2021), Clin Ther

Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy.

Karlsson P. et al, (2021), Diabetologia, 64, 923 - 931

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2021), Nat Med, 27, 279 - 288

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ. et al, (2021), Nat Med, 27, 270 - 278

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Voysey M. et al, (2021), Lancet, 397, 99 - 111

Load More

Include forthcoming?